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Abstract
Background:  Self-administrated patient outcome scores are increasingly recommended for
evaluation of primary outcome in clinical studies. The VISA-P score, developed at the Victorian
Institute of Sport Assessment in Melbourne, Australia, is a questionnaire developed for patients
with patellar tendinopathy and the patients assess severity of symptoms, function and ability to
participate in sport. The aim of this study was to translate the questionnaire into Swedish and to
study the reliability and validity of the translated questionnaire and resultant scores.
Methods:  The questionnaire was translated into Swedish according to internationally
recommended guidelines for cross-cultural adaptation of self-report measures. The reliability and
validity were tested in three different populations. The populations used were healthy students (n
= 17), members of the Swedish male national basketball team (n = 17), considered as a population
at risk, and a group of non-surgically treated patients (n = 17) with clinically diagnosed patellar
tendinopathy. The questionnaire was completed by 51 subjects altogether.
Results: The translated VISA-P questionnaire showed very good test-retest reliability (ICC =
0.97).
The mean (± SD) of the VISA-P score, at both the first and second test occasions was highest in
the healthy student group 83 (± 13) and 81 (± 15), respectively. The score of the basketball players
was 79 (± 24) and 80 (± 23), while the patient group scored significantly (p < 0.05) lower, 48 (±
20) and 52 (± 19).
Conclusions: The translated version of the VISA-P questionnaire was linguistically and culturally
equivalent to the original version. The translated score showed good reliability.
Background
Patellar tendinopathy
Patellar tendinopathy affects athletes in many sports and
at all levels of participation, but is of particular concern
for elite jumping athletes [1]. Many different types of
sport activities have an increased risk for overuse of the
patellar tendon including endurance sports (e.g. long-dis-
tance running and cross-country skiing) and sports with
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repetitive demands on strength and technique (e.g. tennis,
baseball, volleyball, basketball and ballet) [2]. Athletes
who participate in these sports may develop anterior knee
pain that presents as tenderness at the inferior pole of the
patella. This clinical syndrome is commonly called
Jumper's knee, or patellar tendinopathy [3]. The term
tendinopathy is considered to be the most appropriate
clinical description for these chronic painful tendon con-
ditions since there is no evidence of an inflammatory reac-
tion in the chronically degenerated tendon [4,5]. The
changes in the tendon are mainly due to chronic collagen
fiber degeneration [6], but the cause and source of the
pain still remains unclear.
There are few studies on non-surgical treatment of patellar
tendinopathy and there is a lack of evidence-based knowl-
edge evaluating the therapy [7]. In-vivo studies in human
or animals indicate possible benefits from treatments like
heavy pressure [8], therapeutic ultrasound [9] and eccen-
tric strength training [10-14].
Self-rated inventories for knee function
Patient-administrated questionnaires are frequently
applied as primary outcome measures in clinical trials and
several inventories have been translated from English into
Swedish [15-17]. The WOMAC osteoarthritis index has
been tested for reliability and validity in Sweden [18] and
compared to quality of life instruments (SF-36 and NHP)
[19]. The Knee injury and Osteoarthritis Outcome Score
(KOOS) is also a self-administrated instrument measuring
outcome after knee injury at impairment, disability, and
handicap level with five subscales [16]. Garratt et al deter-
mined that KOOS showed good evidence of reliability,
validity and responsiveness, and is recommended the
score for knee diagnosis like ACL reconstruction, total
knee replacements and for arthroplasty patients [20]. The
only published clinical scale for patellar tendinopathy
problems (VISA-P) was developed in Australia by the Vic-
torian Institute of Sport Assessment in Melbourne [21].
The aim was to assess symptoms, simple tests of function
and the ability of subjects to undertake sports. This self-
administrated questionnaire has been documented as a
reliable instrument for monitoring the progress of reha-
bilitation [3,7]. It has also been shown to be a valuable
tool in the assessment and documentation of recovery
from patellar tendinopathy [22]. Even so, the responsive-
ness and validity of the questionnaire have not yet been
fully proven.
The purpose of this study was to translate and cross-cul-
turally adapt the VISA-P score for a Swedish population
and to perform a psychometric analysis as well as reliabil-
ity and initial validity testing of the Swedish VISA-P score.
Methods
Subjects
Fifty-one subjects gave informed consent to participate in
this study. The VISA-P score was administered to 17
healthy students [9 women, 8 men, mean age (± SD) 24
(± 6)]; a population at risk, the Swedish male national
basketball team [17 men, mean age 26 (± 3)], and patients
with the diagnosis patellar tendinopathy [17 men, mean
age 22 (± 5)].
The study was approved by the Ethical Committee at the
Medical Faculty of the Karolinska Institute, Stockholm
(Dnr 00-103).
The VISA-P score
The VISA-P score consists of eight questions [21], of which
six questions concern pain experienced during a range of
everyday activities. Two questions deal with the ability to
engage in sport activities. All questions are answered on
separate scales (0–10), where a higher score indicates a
lower level of pain or impairment (Appendix A) [see addi-
tional file 1]. The maximal total score is 100 points, which
would indicate that the person has no knee pain, good
function and can perform fully in sports. The theoretical
minimum score is 0 points.
The original VISA-P score lacks information about the
selection of items, weighting of each answer and the rank-
ing of the options in the subscales in question 8.
The aim of the present investigation was to get a "working
tool" for further studies of the usefulness of the instru-
ment for patellar tendinopathy patients in Sweden.
Translation procedure
The VISA Tendon Study Group at the University of Mel-
bourne in Australia was informed and gave their consent
to a Swedish translation of their original VISA-P score
(Karim Khan, personal communication, 2003).
The translation process followed the method described by
Beaton et al [23]. This method is currently used by a
number of organizations, including the American Associ-
ation of Orthopaedic Surgeons (AAOS) Outcomes Com-
mittee as they coordinate translations of the different
components of their outcome batteries [23]. The transla-
tion process is divided into five different stages: (I) Trans-
lation, (II) Synthesis, (III) Reverse translation, (IV) Expert
committee review and (V) Pre-testing.
Initially, two physiotherapists performed two independ-
ent translations (I) from English into Swedish. A synthesis
(II) of these translations was made, and the consensus of
the two translated Swedish versions was documented.
Reverse translations (III) were performed independentlyBMC Musculoskeletal Disorders 2004, 5:49 http://www.biomedcentral.com/1471-2474/5/49
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by three native Anglophones fluent in Swedish. One of
the reverse translators was a physiotherapist, one was an
economist and the third was a teacher. The three physio-
therapists in the expert committee (IV) then made a
semantic and idiomatic equivalence analysis between the
original source and target Swedish version of the VISA-P
questionnaire. The translated questionnaire was pre-
tested (V) on 12 individuals, six patients with patellar
tendinopathy and six physical education students.
Test-retest reliability
The Swedish VISA-P score (Appendix B) [see additional
file 2] was administrated to all 51 participants at Bosön,
the Swedish National Sports Confederation Centre (Lid-
ingö, Sweden). The participants completed the question-
naire twice within an interval of one week (range 4–7
days).
The principal investigator administrated the question-
naires at all test occasions, with the exception of six of the
tendinopathy patients.
Validity
For validity, the factor structure of the VISA-P score was
analyzed with a principal component analysis, Varimax
rotation. The number of extracted factors was equal to the
number of eigen values above 1.00. Internal consistency
of subscales, based on the factor analysis, and the total
scale was calculated as a Cronbach α coefficient [24].
For discriminative validity of the VISA-P questionnaires
were compared between three groups, each of which were
expected to have different levels of scoring.
Statistics
All variables were summarized according to standard
descriptive methods [mean and standard deviation (SD)]
and checked for outliers. No significant deviations from
the normal distribution criterion were found. The test-
retest reliability was analyzed according to the method
described by Bland and Altman, which yields an intra-
class correlation (ICC) [25]. Differences between test
occasions and groups were analyzed with an ANOVA
(analysis of variance for repeated measurements, group
*time). In the post-hoc tests of group differences, Tukey's
HSD method was applied. A significance level of five per-
cent was applied (two-tailed).
Results
Translation
The expert committee considered the translation and
reverse translation satisfactory.
Test-retest reliability
The test-retest of the Swedish VISA-P score showed high
reliability and significance (ICC = 0.97, p < 0.001). In Fig-
ure 1, the Bland-Altman plot is showing the difference in
total score between occasion one (A) and occasion two
(B), plotted against the mean value of both test occasions.
There were no significant differences for the total VISA-P
score between the first and second test occasions. Each
question (Q) was analyzed separately regarding the relia-
bility. Seven out of eight questions has a reliability of
more than ICC = 0.8 (range 0.68–0.97).
The score was easy to use and it took about five minutes
to complete.
Internal consistency
The internal consistency of the total scale was high for the
scores both at the first and second occasion, 0.83 and
0.82, respectively.
Factor structure
The principal component analysis yielded a two-factor
solution. The communality, i.e. the degree of explained
variance, of one of the questions (Table 1, "sit pain-free?")
was below 0.35, and thus not sufficiently explained by
this solution. Thus, a three-factor solution was preferred
which explained 85% of the total variance, with all com-
munalities above 0.60. The first component comprised of
six questions. The second and third components com-
prised of one question each. This solution showed high
Bland-Altman plot of the Swedish VISA-P score in the relia- bility (test-retest within 1 week) investigation Figure 1
Bland-Altman plot of the Swedish VISA-P score in the relia-
bility (test-retest within 1 week) investigation. Each blue dot 
indicates the difference in the total score, in relation to the 
mean score, between the two assessments.
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stability, being invariant in a second factor analysis of the
scores from the second occasion (the amount of explained
variance was 83%).
Group differences in the VISA-P score
At the first test occasion (A) the mean (± SD) of the VISA-
P score in the healthy student group was 83 (± 12), in the
basketball players 79 (± 23), and 47 (± 20) in the patient
group (Table 2). In all questions, the patient group had
lower scores as compared to the other two groups and sta-
tistical significance (p < 0.05) was observed in all individ-
ual questions except the first ("sit pain-free"). In Table 1
the post-hoc tests for group differences are presented. The
questions concerning pain ("pain during 10 single leg
hops") had the greatest difference between the groups (F
= 12.7, p < 0.001). Both activity questions ("currently
undertaking sport" and" pain during activity") showed
significant (p < 0.001) differences between the groups.
Discussion
Translation
The expert committee of the translation process expressed
a general agreement of all the questions except one (Q1).
During the translation procedure of the VISA-P score, the
translation for "pain" was debated. Different Swedish
words were discussed and compared between the different
translators. Translations into the mother tongue, or the
first language, more accurately reflected the nuances of the
language. Reverse translation into English of the Swedish
VISA-P version was without remarks. Thus, the original
and translated versions were judged by the expert commit-
tee to be congruent.
Test-retest reliability
Over a time interval of one week (range 4–7 days), the
Swedish version of the VISA-P score showed high reliabil-
ity (ICC = 0.97). As compared to other test-retest investi-
gations of this score, this interval is the longest that has
been studied [21].
Validation of the VISA-P
A factor analysis yielded three factors, of which the first
showed the highest correlations with two questions
("pain during a full weight bearing lunge" and "problems
squatting", see Table 1). The two other factors comprised
only one question each, "currently undertaking sport"
and "sitting pain-free", respectively. The separate factor
for the question about "sitting pain-free" may be an
artefact, as this item was the first one where mispercep-
tions of the response dimension were more likely, thereby
increasing the risk of higher error or unique variance.
Some subjects in the pre-testing group, reported that they
had perceived high scores as more pain. Conceptually,
this question is equivalent to the questions of the first
component. Experiences from the pre-testing resulted in a
more detailed instruction for filling out the Swedish
questionnaire.
Group difference
The patellar tendinopathy patients scored lower for all
questions in the VISA-P score. The basketball players
scored higher than the healthy students in two questions
("sitting pain-free" and "currently undertaking sport", see
Table 2). The first question was the only question that did
not show any statistical significance between the groups
and, noteworthy, the lowest score, i.e. highest degree of
problem. The reason given above regarding the risk of
misperception of the response dimension might be an
explanation.
Table 1: Three-factor solution according to a principal component analysis, Varimax rotation. The questions are ordered after their 
factor loading.
Component
Question I II III h2
Q4. Do you have pain when doing a full weight bearing lunge? 0.92 0.18 0.06 0.88
Q5. Do you have problems squatting? 0.90 -0.09 0.25 0.88
Q6. Do you have pain during or immediately after doing 10 single leg hops? 0.88 0.13 0.26 0.86
Q3. Do you have pain at the knee with full active non-weight bearing knee extension? 0.77 0.26 0.12 0.68
Q8. For how long can you manage being train/physically active? 0.75 0.39 0.11 0.73
Q2. Do you have pain walking downstairs with a normal gait cycle? 0.70 0.38 0.24 0.69
Q1. For how many minutes can you sit pain free? 0.23 0.13 0.96 0.99
Q7. Are you currently undertaking sport or other physical activity? 0.17 0.95 0.11 0.94BMC Musculoskeletal Disorders 2004, 5:49 http://www.biomedcentral.com/1471-2474/5/49
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The VISA-P score has not yet been validated for patholog-
ical knee conditions other than patellar tendinopathy.
Considering the separate questions (Appendix A) [see
additional file 1] it would be of interest to test the VISA-P
score for patients with anterior knee pain other than patel-
lar tendinopathy.
The significantly higher scores of the basketball players in
question 7, "currently undertaking sport" (Table 2) were
trivial and obvious, since all of them were active players in
Swedish the national team. The standard deviation was
nearly twice as high for the patients and basketball players
as compared to the healthy students. This reflects the het-
erogeneity of the first two groups.
Generally, there is a debate concerning scores about the
relevance of using the total score or dividing the score in
different subgroups. A short clinical scale is often an
advantage. The factor analysis as well as the analysis of dif-
ferences between the groups suggests that the VISA-P score
Table 2: Mean score and standard deviation (SD) in three groups of subjects: patients with patellar tendinopathy (P); basket-ball 
players (B); and healthy students (H), and analysis of variance (ANOVA) of group differences of the Swedish VISA score.
Patients (n = 17) Basketball (n = 17) Healthy student (n = 17) Total (n = 51) ANOVA
Question Occasion M SD M SD M SD M SD F p Tukey
Q1. For how many 
minutes can you sit 
pain free?
A 5.41 2.94 7.53 2.88 7.24 3.52 6.73 3.21 2.29 n.s ns
B 6.06 2.80 7.82 2.65 7.18 3.63 7.02 3.08
Q2. Do you have pain 
walking down-stairs 
with a normal gait 
cycle?
A 5.94 2.35 8.47 2.81 8.94 1.34 7.78 2.58 8.70 p < 0.001 P < B;P < H
B 6.94 2.02 8.82 1.98 8.41 2.18 8.06 2.18
Q3. Do you have pain 
at the knee with full 
active non-weight 
bearing knee 
extension?
A 6.59 3.00 8.47 2.53 9.53 1.06 8.20 2.61 6.84 p < 0.05 P < H
B 6.29 2.44 8.82 1.97 9.18 1.33 8.10 2.33
Q4. Do you have pain 
when doing a full 
weight bearing lunge?
A 4.41 2.89 7.65 3.08 8.06 2.19 6.71 3.16 8.97 p < 0.05 p < B;p < H
B 5.24 2.86 7.88 2.83 8.00 2.24 7.04 2.91
Q5. Do you have 
problems squatting?
A 5.76 2.28 7.35 3.26 8.24 1.98 7.12 2.71 4.05 p < 0.05 p < H
B 6.65 2.47 7.76 2.88 8.18 2.27 7.53 2.58
Q6. Do you have pain 
during or immediately 
after doing 10 single 
leg hops?
A 3.29 2.33 6.65 3.62 8.18 2.55 6.04 3.50 12.6
6
p < 0.001 p < B;p < H
B 4.29 2.87 6.71 3.88 8.18 2.04 6.39 3.38
Q7. Are you 
currently undertaking 
sport or other 
physical activity?
A 5.00 2.48 9.47 1.58 7.35 2.98 7.27 3.00 14.5
7
p < 0.001 p < H<B
B 4.41 2.62 9.47 1.58 7.00 2.81 6.96 3.14
Q8. For how long can 
you manage being 
train/physically active?
A 11.35 10.94 23.41 8.27 25.53 5.68 20.10 10.50 13.5
4
p < 0.001 p < B;p < H
B 12.41 10.25 22.82 8.13 25.53 5.68 20.25 9.86
Total score A 47.76 20.26 79.00 24.18 83.06 12.60 69.94 24.96 16.4
8
p < 0.001 p < B;p < H
B 52.29 18.98 80.12 22.82 81.65 15.48 71.35 23.33BMC Musculoskeletal Disorders 2004, 5:49 http://www.biomedcentral.com/1471-2474/5/49
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could be abbreviated to two or three items without losing
significant clinical information (Table 1).
An important aspect of a clinical scale is its sensitivity for
change or its ability to follow amelioration or exacerba-
tion during treatment. The theoretical range of the VISA
score, i.e. the floor and ceiling, is 0–100. The mean total
score of the patients was approximately 50 (with a mini-
mum value of 16) and for the control groups 80 (with a
maximum value of 100. Thus, there seems to be sufficient
scope to follow treatment effects, as well as to follow dete-
riorations of a risk group. It should be noted, however,
that the present study was not designed to study treatment
effects or development of a pathological process. The con-
clusion regarding the sensitivity of the VISA score, thus,
awaits empirical support.
Although the mean VISA-P scoring was significantly dif-
ferent between asymptomatic subjects and patients with
patellar tendinopathy, the score is not suggested to be a
diagnostic test [21]. Therefore the score is considered to be
suitable for group and intra-individual comparisons but
should be avoided in inter-individual comparison.
Another limitation of the score has not been shown to be
applicable in a non-athletic population.
Adaptation of a questionnaire for use in a new setting is
time consuming and costly. There are specific criteria that
investigators should apply when evaluating patient-based
outcome measures [26]. That being the case, larger inter-
national data collections and better correlations can be
made when proper translations are performed and evalu-
ations conducted. Additionally, there is a need for interna-
tional accepted 'golden standards' in outcome scores.
In conclusion, the results of the present study suggest that
the translated Swedish version (Appendix B) [see addi-
tional file 2] of the original Australian VISA-P score
(Appendix A) [see additional file 1] had satisfactory test-
retest reliability when used to evaluate symptoms, tests of
function and ability to undertake sport in patients with
patellar tendinopathy.
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